Dr Claude Leclerc, PhD in immunology from the University of Paris VII, France. She is currently Director of DEA graduate programme in Immmunology at the University Paris VII as well as Immunology professor at the Institut Pasteur. Claude is also Head the Department for Biology of Immune Regulation and Director of Institut Pasteur Cancéropôle. For her research in immunology, Dr Leclerc was awarded the George Zermati Prize in 1996 and the Cancer Paris Distinction by the Leaque against Cancer (2004). Dr Leclerc is a co-inventor of BT PHARMA’s key technology platform, the adenylate cyclase antigen delivery technology (CyaA).

Dr Larry Gold, PhD, is Professor of the Molecular, Cellular and Developmental Biology Department at the University of Boulder, Colorado, USA. In 1993, Larry was elected member of the American Society of Arts and Sciences and in 1995 as a member of the National Academy of Sciences of the USA. Dr Gold has 25 years experience in leading Biotechnology companies: he was founder and CSO of SYNERGEN (1981) and NEXSTAR (1992). In 1999, Larry founded Somalogics Inc., based in Boulder, Co. of which he is currently CEO and Chairman of the Board.

Dr Alessandro Sette obtained his PhD in Immunology at the University of Rome. Dr Sette has been granted many scientific awards during his career such as by the American Association of Immunologists, the American Liver Foundation and the ISI award for highest scientific citation. Dr Sette was scientific co-founder of Cytel Corp. (1988) and founder and CSO of Epimmune (1997 – 2002). Today Dr Sette is professor of Immunology at the University of California, San Diego, CA, USA and Director of the Bio-defence and Vaccinology Unit at the La Jolla Institute for Allergy and Immunology.